| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 17 |
| 1 | PREDNISOLONE | 14 |
| 2 | PREDNISOLONE ORAL | 14 |
| 3 | PREDNISOLONE ORAL SOLUTION | 14 |
| 4 | CYCLOPHOSPHAMIDE | 12 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 7 | OBINUTUZUMAB | 12 |
| 8 | OCRELIZUMAB | 10 |
| 9 | PREDNISONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRANACOGENE DEZAPARVOVEC | 1 | 0.0154 |
| 1 | TREOSULFAN | 4 | 0.0014 |
| 2 | ANIFROLUMAB-FNIA | 2 | 0.0010 |
| 3 | SODIUM FERRIC GLUCONATE COMPLEX | 2 | 0.0009 |
| 4 | OBINUTUZUMAB | 12 | 0.0007 |
| 5 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 6 | THIOTEPA | 4 | 0.0004 |
| 7 | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0004 |
| 8 | SOTALOL HYDROCHLORIDE TABLES AF | 1 | 0.0004 |
| 9 | SOTALOL HYDROCHLORIDE TABLETS AF | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 42 | 0.0001 |
| 4 | Integrin Receptor Antagonist [EPC] | 6 | 0.0001 |
| 5 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 9 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |